Operating Segments (Tables)

12 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Schedule of operating segments

	For the Years Ended December 31,
	2019			2018
Revenues
Public Health Solutions	$	3,402,014		$	4,156,641
Specialized BioTherapeutics		1,227,902			1,084,807
Total	$	4,629,916		$	5,241,448
Income (Loss) from Operations
Public Health Solutions	$	153,969		$	(237,640	)
Specialized BioTherapeutics		(6,738,284	)		(5,439,294	)
Corporate		(3,956,706	)		(3,382,047	)
Total	$	(10,541,021	)	$	(9,058,981	)
Amortization and Depreciation Expense
Public Health Solutions	$	17,507		$	17,951
Specialized BioTherapeutics		18,122			21,018
Corporate		18,821			5,091
Total	$	54,450		$	44,060
Other Income, Net
Specialized BioTherapeutics	$	425,785			-
Corporate		148,968			159,006
Total	$	574,753		$	159,006
Share-Based Compensation
Public Health Solutions	$	36,003		$	57,307
Specialized BioTherapeutics		107,214			117,570
Corporate		233,122			206,009
Total	$	376,339		$	380,886

	As of December 31,
	2019		2018
Identifiable Assets
Public Health Solutions	$	1,018,673	$	1,181,114
Specialized BioTherapeutics		41,705		78,336
Corporate		6,714,983		9,232,252
Total	$	7,775,360	$	10,491,702